MACITENTAN and COUGH

Overview

COUGH is the #11 most commonly reported adverse reaction for MACITENTAN, manufactured by Actelion Pharmaceuticals US, Inc.. There are 3,772 FDA adverse event reports linking MACITENTAN to COUGH. This represents approximately 2.0% of all 188,657 adverse event reports for this drug.

Patients taking MACITENTAN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for MACITENTAN, but still significant enough to appear in the safety profile.

Other Side Effects of MACITENTAN

In addition to cough, the following adverse reactions have been reported for MACITENTAN:

• DYSPNOEA — 11,679 reports
• HEADACHE — 8,041 reports
• DEATH — 7,277 reports
• DIARRHOEA — 6,397 reports
• NAUSEA — 5,813 reports
• FATIGUE — 4,870 reports
• PNEUMONIA — 4,468 reports
• DIZZINESS — 4,380 reports
• HOSPITALISATION — 4,042 reports
• FLUID RETENTION — 3,777 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does MACITENTAN cause COUGH?

COUGH has been reported as an adverse event in 3,772 FDA reports for MACITENTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with MACITENTAN?

COUGH accounts for approximately 2.0% of all adverse event reports for MACITENTAN, making it a notable side effect.

What should I do if I experience COUGH while taking MACITENTAN?

If you experience cough while taking MACITENTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages